Financhill
Sell
49

FULC Quote, Financials, Valuation and Earnings

Last price:
$12.06
Seasonality move :
-11.85%
Day range:
$11.85 - $12.29
52-week range:
$2.32 - $15.74
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
3.28x
Volume:
416K
Avg. volume:
2M
1-year change:
163.96%
Market cap:
$650M
Revenue:
$80M
EPS (TTM):
-$1.18

Earnings Data

Next earnings date for FULC
Feb 24
2026
Most recent earnings per share
-$0.31
Missed by $0.02
(Oct 29/2025)
Consensus Estimate
-$0.29
(Oct 29/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

FULC Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
02/24/2026 Q4 -- -- -- -$0.31 --
10/29/2025 Q3 -- -- -$0.31 -$0.29 -$0.02
07/29/2025 Q2 -- -- -$0.28 -$0.29 $0.01
05/13/2025 Q1 -- -- -$0.28 -$0.33 $0.04
02/25/2025 Q4 -- -- -$0.31 -$0.29 -$0.02
11/13/2024 Q3 -- -- -$0.35 -$0.40 $0.05
07/31/2024 Q2 $41.1M $80M $0.87 $0.06 $0.81
05/13/2024 Q1 $360.1K -- -$0.43 -$0.44 $0.00
02/27/2024 Q4 $394.8K $871K -$0.40 -$0.43 $0.03
11/07/2023 Q3 $1.1M $759K -$0.39 -$0.44 $0.05
08/03/2023 Q2 -- $880K -$0.38 -- --
05/15/2023 Q1 -- $295K -$0.41 -- --
03/09/2023 Q4 -- $685K -$0.50 -- --
11/08/2022 Q3 -- $1.2M -$0.51 -- --
08/11/2022 Q2 -- $1.9M -$0.83 -- --
05/09/2022 Q1 -- $2.6M -$0.64 -- --
03/03/2022 Q4 -- $5.1M -$0.58 -- --
11/04/2021 Q3 -- $4.9M -$0.57 -- --
08/10/2021 Q2 -- $4.4M -$0.60 -- --
05/06/2021 Q1 -- $4.8M -$0.54 -- --
03/04/2021 Q4 -- $4.2M -$0.64 -- --
11/10/2020 Q3 -- $1.8M -$0.70 -- --
08/11/2020 Q2 -- $2M -$0.66 -- --
05/13/2020 Q1 -- $750K -$0.81 -- --
03/05/2020 Q4 -- -- -$0.71 -- --
11/14/2019 Q3 -- -- -$0.97 -- --
08/26/2019 Q2 -- -- -$0.71 -- --
03/31/2019 Q1 -- -- -$1.71 -- --
12/31/2018 Q4 -- -- -$0.69 -- --
09/30/2018 Q3 -- -- -$0.64 -- --
06/30/2018 Q2 -- -- -$0.53 -- --
03/31/2018 Q1 -- -- -$0.33 -- --

Fulcrum Therapeutics, Inc. Earnings Questions

  • How Much did Fulcrum Therapeutics, Inc. Generate in Revenue Last Quarter?

    Fulcrum Therapeutics, Inc. reported -- worth of top line sales in its most recent quarter.

  • Did Fulcrum Therapeutics, Inc. Beat Earnings Last Quarter?

    Fulcrum Therapeutics, Inc. announced earnings per share of -$0.31 which represents a miss of analyst forecast a -$0.29 per share.

  • Is Fulcrum Therapeutics, Inc. Profitable?

    Fulcrum Therapeutics, Inc. reported -$300K that represents -$0.00 per share over the last quarter.

  • What is the Analyst Consensus for Fulcrum Therapeutics, Inc. EPS Next Year?

    Fulcrum Therapeutics, Inc.'s earnings are forecast to decrease from -$0.16 per share to -$0.14 per share next year representing a decrease of -648.89%.

  • When is Fulcrum Therapeutics, Inc.'s Earnings Date?

    Fulcrum Therapeutics, Inc.'s next earnings date is February 24, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
57
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
55
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
80
TVTX alert for Dec 25

Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.

Buy
68
KOD alert for Dec 25

Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.

Buy
64
ZCSH alert for Dec 25

Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock